Ballicules.com

Guanabenz

WYTENSIN

Pronunciation: GWAHN-a-benz

Guanabenz ballicule: receptor binding, kinetics and half-life diagram
Mechanism of action: Guanabenz ballicule

What it isCentral alpha-2 agonist; hypertension.

Why this oneClonidine-like agent retained where clonidine is not tolerated.

What limits itRebound hypertension on withdrawal, sedation and dry mouth. Now rarely used.

Guanabenz molecular structure (skeletal formula)
Molecular structure: Guanabenz

Guanabenz prescription history

Animated chart of estimated U.S. prescriptions per year, Antihypertensives (1953–2026). Guanabenz enters in 1982 (estimated).

FDA-approved for

NO BOXED WARNINGS

Principal riskRebound hypertension on withdrawal, sedation and dry mouth

Classes and tags

Clinical profile

Therapeutic safety burden2 / 4
Overdose danger2 / 4
Weight-gain liability0 / 4
Sedation liability2 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk2 / 4

Legacy pregnancy categoryC

Defining liabilitySedation, bradycardia and rebound hypertension

Open Guanabenz in the interactive console ↗

Self-check